On Cancer: Clinical Trials

Print
and/or
136 Blog posts found

In The Clinic

FDA Approves Pexidartinib, a Targeted Therapy for a Tumor of the Joints

Pexidartinib is the first drug approved specifically to treat tenosynovial giant cell tumor.

Medical oncologist William Tap

In the Clinic

5 Reasons MSK Excels at Treating Gynecologic Cancers

Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.

Memorial Sloan Kettering surgeons Oliver Zivanovic, Kara Long Roche, Ginger Gardner, and Yukio Sonoda

Roundup

Highlights from ASCO 2019: Progress in Treating Cancer in Children

MSK Kids doctors report advances in treating pediatric cancers at the 2019 meeting of the American Society of Clinical Oncology.

Crowd shot at ASCO 2019

Q & A

What Can Be Learned from a Negative Clinical Trial? Findings from a Sarcoma Study at ASCO 2019

At the ASCO meeting in Chicago, MSK medical oncologist William Tap talked about disappointing results from a new sarcoma drug, which didn’t increase survival.

Medical oncologist William Tap

In The Clinic

Prestigious Grant Bolsters Bladder Cancer Research at MSK

A prominent research grant will enable MSK doctors and scientists to advance the treatment of bladder cancer.

Conceptual orange-and-green-colored X-ray showing cancer of the bladder.

In the Clinic

Giving Drugs before Surgery Lowers the Risk of Prostate Cancer Returning

Giving a two-drug combination before prostate cancer surgery appears to reduce the chance that some high-risk forms of the disease will come back.

Memorial Sloan Kettering prostate cancer surgeon James Eastham with colleague.

Q & A

How MSK Is Reducing Inequality in Cancer Care in Harlem and Beyond

Medical Director Lewis Kampel discusses the mission and goals of the Ralph Lauren Center for Cancer Care.

Lewis Kampel speaks to a staff member

In The News

New Collaboration Will Accelerate US-China Clinical Trials

The initiative lays the groundwork for speedier cancer drug approvals in both the United States and China.

MSK President Craig Thompson

In the Clinic

When a Cancer Therapy Stops Working: Experimental Drug Addresses Resistance

Results from the first phase I clinical trial of a new drug were presented at the American Association for Cancer Research’s meeting.

MSK medical oncologist David Hyman